XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A and B common stock
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Retained earnings (Accumulated deficit)
Retained earnings (Accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2019     432,796,720            
Beginning balance at Dec. 31, 2019 $ 1,715,050   $ 0 $ 2,223,749   $ 1,629 $ (510,328)   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (105,891)           (105,891)    
Shares issued in connection with employee stock plans (in shares)     5,222,525            
Shares issued in connection with employee stock plans 31,406     31,406          
Change in other comprehensive loss (5,061)         (5,061)      
Share-based compensation 79,562     79,562          
Tax withholding related to vesting of restricted stock units (in shares)     (722,606)            
Tax withholding related to vesting of restricted stock units (48,772)     (48,772)          
Conversion feature of convertible senior notes, due 2025, net of allocated costs 152,258     152,258          
Purchase of bond hedges in conjunction with issuance of convertible senior notes, due 2025 (149,200)     (149,200)          
Sale of warrants in conjunction with issuance of convertible senior notes, due 2025 99,500     99,500          
Issuance of common stock in conjunction with the conversion of convertible notes (in shares)     1,109,980            
Issuance of common stock in conjunction with the conversion of convertible notes 24,094     24,094          
Issuance of common stock in connection with business combination (in shares)     357,017            
Issuance of common stock in connection with business combination 14,999     14,999          
Ending balance (in shares) at Mar. 31, 2020     438,763,636            
Ending balance at Mar. 31, 2020 1,807,945   $ 0 2,427,596   (3,432) (616,219)   0
Beginning balance (in shares) at Dec. 31, 2019     432,796,720            
Beginning balance at Dec. 31, 2019 1,715,050   $ 0 2,223,749   1,629 (510,328)   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (80,854)                
Ending balance (in shares) at Sep. 30, 2020     447,695,197            
Ending balance at Sep. 30, 2020 2,062,835   $ 0 2,642,107   11,910 (591,182)   0
Beginning balance (in shares) at Mar. 31, 2020     438,763,636            
Beginning balance at Mar. 31, 2020 1,807,945   $ 0 2,427,596   (3,432) (616,219)   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (11,478)           (11,478)    
Shares issued in connection with employee stock plans (in shares)     4,802,969            
Shares issued in connection with employee stock plans 46,679     46,679          
Change in other comprehensive loss 7,798         7,798      
Share-based compensation 99,925     99,925          
Tax withholding related to vesting of restricted stock units (in shares)     (703,895)            
Tax withholding related to vesting of restricted stock units (44,882)     (44,882)          
Exercise of bond hedges in conjunction with the conversion of convertible notes (in shares)     (724,316)            
Issuance of common stock in connection with business combination (in shares)     250,957            
Issuance of common stock in connection with business combination 20,320     20,320          
Ending balance (in shares) at Jun. 30, 2020     442,389,351            
Ending balance at Jun. 30, 2020 1,926,307   $ 0 2,549,638   4,366 (627,697)   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 36,515           36,515    
Shares issued in connection with employee stock plans (in shares)     4,246,489            
Shares issued in connection with employee stock plans 28,514     28,514          
Change in other comprehensive loss 7,544         7,544      
Share-based compensation 114,172     114,172          
Tax withholding related to vesting of restricted stock units (in shares)     (694,266)            
Tax withholding related to vesting of restricted stock units (88,953)     (88,953)          
Issuance of common stock in conjunction with the conversion of convertible notes (in shares)     1,753,623            
Issuance of common stock in conjunction with the conversion of convertible notes 38,736     38,736          
Ending balance (in shares) at Sep. 30, 2020     447,695,197            
Ending balance at Sep. 30, 2020 2,062,835   $ 0 2,642,107   11,910 (591,182)   0
Beginning balance (in shares) at Dec. 31, 2020     456,184,776            
Beginning balance at Dec. 31, 2020 2,681,569 $ (399,734) $ 0 2,955,464 $ (502,708) 23,328 (297,223) $ 102,974 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 39,008           39,008    
Shares issued in connection with employee stock plans (in shares)     4,311,094            
Shares issued in connection with employee stock plans 32,891     32,891          
Change in other comprehensive loss (13,129)         (13,129)      
Share-based compensation 121,965     121,965          
Tax withholding related to vesting of restricted stock units (in shares)     (669,076)            
Tax withholding related to vesting of restricted stock units (152,013)     (152,013)          
Issuance of common stock in conjunction with the conversion of convertible notes (in shares)     166,967            
Issuance of common stock in conjunction with the conversion of convertible notes 3,816     3,816          
Exercise of bond hedges in conjunction with the conversion of convertible notes (in shares)     (5,325,320)            
Ending balance (in shares) at Mar. 31, 2021     454,668,441            
Ending balance at Mar. 31, 2021 $ 2,314,373   $ 0 2,459,415   10,199 (155,241)   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06                
Beginning balance (in shares) at Dec. 31, 2020     456,184,776            
Beginning balance at Dec. 31, 2020 $ 2,681,569 $ (399,734) $ 0 2,955,464 $ (502,708) 23,328 (297,223) $ 102,974 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 239,810                
Ending balance (in shares) at Sep. 30, 2021     460,979,653            
Ending balance at Sep. 30, 2021 3,004,714   $ 0 2,918,372   (7,411) 48,864   44,889
Beginning balance (in shares) at Mar. 31, 2021     454,668,441            
Beginning balance at Mar. 31, 2021 2,314,373   $ 0 2,459,415   10,199 (155,241)   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 203,678           204,021   (343)
Shares issued in connection with employee stock plans (in shares)     2,410,350            
Shares issued in connection with employee stock plans 39,526     39,526          
Change in other comprehensive loss (2,361)         (2,361)      
Share-based compensation 150,367     150,367          
Tax withholding related to vesting of restricted stock units (in shares)     (602,961)            
Tax withholding related to vesting of restricted stock units (140,212)     (140,212)          
Issuance of common stock in conjunction with the conversion of convertible notes (in shares)     1,456,748            
Issuance of common stock in conjunction with the conversion of convertible notes 113,067     113,067          
Exercise of bond hedges in conjunction with the conversion of convertible notes (in shares)     (150,299)            
Issuance of common stock in connection with business combination (in shares)     41,138            
Issuance of common stock in connection with business combination 10,071     10,071          
Noncontrolling interests in connection with business combination 48,192               48,192
Ending balance (in shares) at Jun. 30, 2021     457,823,417            
Ending balance at Jun. 30, 2021 2,736,701   $ 0 2,632,234   7,838 48,780   47,849
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (2,876)           84   (2,960)
Shares issued in connection with employee stock plans (in shares)     3,065,151            
Shares issued in connection with employee stock plans 12,711     12,711          
Change in other comprehensive loss (15,249)         (15,249)      
Share-based compensation 168,585     168,585          
Tax withholding related to vesting of restricted stock units (in shares)     (82,374)            
Tax withholding related to vesting of restricted stock units (20,181)     (20,181)          
Issuance of common stock in conjunction with the conversion of convertible notes (in shares)     1,371,519            
Issuance of common stock in conjunction with the conversion of convertible notes 106,359     106,359          
Exercise of bond hedges in conjunction with the conversion of convertible notes (in shares)     (1,275,365)            
Issuance of common stock in connection with business combination (in shares)     77,305            
Issuance of common stock in connection with business combination 18,664     18,664          
Ending balance (in shares) at Sep. 30, 2021     460,979,653            
Ending balance at Sep. 30, 2021 $ 3,004,714   $ 0 $ 2,918,372   $ (7,411) $ 48,864   $ 44,889